Class III
Drug Recall: Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
AVEVA Drug Delivery Systems, Inc. · May 14, 2026
Reason for Recall
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Distribution
Nationwide within the U.S
States Affected
NATIONWIDE
Quantity Affected
59,808 pouches (4,272 Individual Folding Carton (IFC))
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0550-2026
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.